This page shows the latest medicines use news and features for those working in and with pharma, biotech and healthcare.
The ADC has been recommended with doxorubicin, vinblastine and dacarbazine. Takeda has announced that the European Medicines Agency’s human medicines committee has recommended Adcetris (brentuximab vedotin) as part of a ... The CHMP’s recommendation
If approved, Veklury would become the first COVID-19 antiviral authorised for use across all stages of liver disease. ... Gilead Sciences has announced that its COVID-19 treatment Veklury (remdesivir) has been recommended by the European Medicines
The collaboration will focus on advancing a new class of medicines for use in cancer. ... Seagen and Nurix Therapeutics have entered into a multi-year, multi-target strategic collaboration agreement worth more than $3.4bn, to advance a new class of
A new study published in BMJ Global Health has revealed that over 500, 000 deaths associated with antimicrobial resistance (AMR) could be averted each year with the effective use of existing ... AMR occurs when bacteria, viruses, fungi and parasites
The new recommendations consist of 85 applications spanning over 100 medicines and formulations that were considered by the WHO Expert Committee on Selection and Use of Essential Medicines. ... on which medicines are the best value in terms of benefits
Roche’s spinal muscular atrophy (SMA) therapy has been recommended by the European Medicines Agency’s human medicines committee for use in infants aged under two months. ... The Committee for Medicinal Products for Human Use (CHMP) has recommended
More from news
Approximately 0 fully matching, plus 296 partially matching documents found.
Here are the key takeaways:. Suboptimal decision-making by HCPs. More than 50% of all medicines are prescribed, dispensed or sold inappropriately and about 50% of patients do not take medicines ... correctly. From irrational use of medicines, clinical
Real-world evidence (RWE): the use of real-world data (RWD) and RWE is gaining prominence in healthcare decision-making. ... By bridging scientific knowledge, clinical practice and regulatory compliance, medical affairs contributes to the safe and
Similarly, long-term challenges around the licensing of medicines for use in the UK, as well as the expected additional workload and cost that this will entail for industry, on top ... With three COVID-19 vaccines approved for use in the UK at the time
Access to healthcare, including affordable medicines, remains a top concern across the US. ... This can help expand options for chronically ill patients and allow greater use of biologic medicines by providing more affordable access to individuals who,
The FDA has just granted Roche emergency use authorisation (EUA) for its new test to detect the virus that causes the coronavirus. ... Secondly, the revised Patents Act encourages the development of safe medicinal products for paediatric use.
More from intelligence
Approximately 1 fully matching, plus 42 partially matching documents found.
Prior to joining Accord, Grosso held a number of senior public and commercial roles, including the role of principal medicines management pharmacist at UCL Hospitals. ... Grosso is also a registered pharmacist, and has a long-standing interest in the
the access to and use of new and innovative medicines for Scottish patients. ... and innovative medicines.”.
team. “His experience in both government and the pharmaceutical industry will prove invaluable when addressing the issues of access and use of new medicines in the NHS and in leading discussions
As president of the EAHP, Peppard will look to advance the organisation's mission to develop hospital pharmacy in order to promote the best and safest use of medicines and medical
Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access. ... greater use of newer medicines,” added Catchpole.
More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.
WITHOUT EFFECTIVE AND APPROPRIATE USE OF ANTIMICROBIALS, WE WILL LOSE DECADES OF PROGRESS IN MODERN MEDICINE. ... AMR is a naturally occurring phenomenon, but it has been considerably sped up by human behaviours and systems, including travel, over or
But what do they mean for medicines? In his latest blog, Hanover Health’s Andrew Harrison argues that there is a need for a renewed value story for medicines in the ... A government review in 2005 noted the low and slow use of medicines in the NHS, and
“Take up of new medicines in the UK continues to be slow by international standards”. ... Yet with the sector seen as crucial to economic regeneration post-Brexit and post-pandemic, the slower use of innovative medicines in the UK is a drag anchor on
Targeted therapies for ovarian cancer. In 2011, the European Medicines Agency (EMA) approved the use of targeted therapies, including an anti-angiogenic treatment alongside chemotherapy to increase the effectiveness of treatment ... 10. European
by 2020/21 if the NHS embraces the use of best value biological medicines in a proactive, systematic and safe way’. ... The best biologics agenda and pharma. In line with the Commissioning Framework for Biological Medicines, NHS England, NHS
More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.
No results were found
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...